Sycamore Partners completes $8.25B acquisition of Walgreens Boots Alliance; stock delisted

Walgreens Boots Alliance, Inc.

Shareholders receive $11.45 per share cash plus one contingent right for up to $3.00 from future VillageMD monetization.
WBA common stock and listed notes ceased trading on Nasdaq; company will file Form 15 to end SEC reporting.
Stefano Pessina reinvested 100% of his WBA interests; remains on board alongside Sycamore's Stefan Kaluzny and Kevin Burke.
Mike Motz appointed CEO of Walgreen Co., replacing Tim Wentworth; Walgreens operates as standalone private company.
Outstanding credit facilities terminated; tender offer for multiple series of notes completed with amendments to indentures.

item 1.01item 1.02item 2.01item 3.01item 3.03item 5.01item 5.02item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.